These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23483312)

  • 41. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.
    Shao JJ; Wong CK; Lin T; Lee SK; Cong GZ; Sin FW; Du JZ; Gao SD; Liu XT; Cai XP; Xie Y; Chang HY; Liu JX
    Clin Vaccine Immunol; 2011 Jan; 18(1):143-9. PubMed ID: 21084463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-cell immunogen shows enhanced immunogenicity in mice.
    Cao Y; Lu Z; Sun P; Fu Y; Tian F; Hao X; Bao H; Liu X; Liu Z
    Virol J; 2011 Feb; 8():77. PubMed ID: 21342530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction and immune response characterization of a recombinant pseudorabies virus co-expressing capsid precursor protein (P1) and a multiepitope peptide of foot-and-mouth disease virus in swine.
    He Y; Qian P; Zhang K; Yao Q; Wang D; Xu Z; Wu B; Jin M; Xiao S; Chen H
    Virus Genes; 2008 Apr; 36(2):393-400. PubMed ID: 18246420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
    Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination.
    Guzman E; Taylor G; Charleston B; Ellis SA
    J Virol; 2010 Dec; 84(23):12375-84. PubMed ID: 20861264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination.
    Mu S; Chen L; Dong H; Li S; Zhang Y; Yin S; Tian Y; Ding Y; Sun S; Shang S; Guo H
    J Virol; 2024 Feb; 98(2):e0200223. PubMed ID: 38289108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.
    Lee HB; Piao DC; Lee JY; Choi JY; Bok JD; Cho CS; Kang SK; Choi YJ
    Microb Cell Fact; 2017 Feb; 16(1):33. PubMed ID: 28228147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoprotective mechanisms in swine within the "grey zone" in antibody response after immunization with foot-and-mouth disease vaccine.
    Zhang L; Feng X; Jin Y; Ma J; Cai H; Zhang X
    Virus Res; 2016 Jul; 220():39-46. PubMed ID: 27067203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
    Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
    Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus--importance of dominant and subdominant epitopes for antigenicity and protection.
    Frimann TH; Barfoed AM; Aasted B; Kamstrup S
    Vaccine; 2007 Aug; 25(33):6191-200. PubMed ID: 17640782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA prime-protein boost strategy with replicase-based DNA vaccine against foot-and-mouth disease in bovine calves.
    Dar PA; Suryanaryana VS; Nagarajan G; Reddy GR; Dechamma HJ; Kondabattula G
    Vet Microbiol; 2013 Apr; 163(1-2):62-70. PubMed ID: 23305616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.